Showing 1,460 news articles about Pharmaceutical industry

Filters Content type: Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

New & experimental hepatitis C treatment

What Is a Hepatitis C Drug Worth?

Editor's pick
Roll Call
14 January 2014
Access to healthcare

Global Fund tiered pricing plan for ARVs, other health commodities raises questions

Editor's pick
Science Speaks
11 January 2014
Pharmaceutical industry

Brazil govt "hindering market entry of new HIV drugs"

Editor's pick
Pharma Times
8 January 2014
Pharmaceutical industry

Gilead Sales Chief Retires Amidst Key Hep C Drug Launch, Massive Insider Selling

Editor's pick
The Street
7 January 2014
New & experimental HIV treatments

Vertex's VX-765 holds promise for HIV treatment

Editor's pick
Motley Fool
7 January 2014
New & experimental hepatitis C treatment

$1000 Pill For Hepatitis C Spurs Debate Over Drug Prices

Editor's pick
NPR (blog)
6 January 2014
Pharmaceutical industry

Lack of drug data 'extreme concern'

Editor's pick
BBC Health
3 January 2014
Hepatitis C treatment

Gilead Sciences, Inc. (GILD): Gilead Seeks To Expand Its Blockbuster Hepatitis Platforms In 2014

Editor's pick
Seeking Alpha
3 January 2014
Pharmaceutical industry

A Year-End Look At HIV Treatments in 2013

Editor's pick
Motley Fool
29 December 2013
New & experimental HIV treatments

Lupin launches HIV drug in the US

Editor's pick
The Hindu
19 December 2013
New & experimental hepatitis C treatment

Gilead Announces SVR12 Rates From Three Phase 3 Studies Evaluating a Once-Daily Fixed-Dose Combination of Sofosbuvir and Ledipasvir for Genotype 1 Hepatitis C Patients

Editor's pick
Gilead press release
18 December 2013
New & experimental hepatitis C treatment

Gilead to seek okay for combo hepatitis C pill in first quarter

Editor's pick
Reuters
18 December 2013
New & experimental hepatitis C treatment

Analysis: Fight for cheap drugs shifts from AIDS to new hepatitis pills

Editor's pick
Reuters
16 December 2013
Changing treatment

U.S. FDA Approves Gilead’s Once-Daily Single Tablet HIV-1 Regimen Complera® for Patients Switching from a Stable Regimen

Editor's pick
Gilead press release
16 December 2013
Access to healthcare

US: Group Says Plans Discourage HIV Patients

Editor's pick
Wall Street Journal
12 December 2013
Pharmaceutical industry

Bristol-Myers Squibb adds medicine to patent pool for AIDS drugs

Editor's pick
Reuters
12 December 2013
New & experimental hepatitis C treatment

Why Talk Of A Hepatitis C Price War Should Act As A Warning To The Pharma Industry-At-Large

Editor's pick
Forbes
11 December 2013
New & experimental hepatitis C treatment

Express Scripts Pushes Price Competition for Gilead Drug

Editor's pick
Bloomberg
11 December 2013
Pharmaceutical industry

Activists Condemn Gilead for Exorbitant Price of Their New Hepatitis C Drug

Editor's pick
Fair Pricing Coalition / The Body
10 December 2013
Pharmaceutical industry

Fair Pricing Coalition Disappointed by the High Price of New Janssen Hepatitis C Drug Olysio (simeprevir)

Editor's pick
Fair Pricing Coalition
29 November 2013
Access to healthcare

Indian health activists move to prevent Gilead’s drug patent

Editor's pick
Financial Times
26 November 2013
Pharmaceutical industry

Hardly accessible Atripla in Eastern Europe & Central Asia

Editor's pick
EATG / EECA CAB
22 November 2013
New & experimental hepatitis C treatment

How Much? A Battle Over The Cost Of The New Hepatitis C Drugs

Editor's pick
Pharmalot
12 November 2013
Types of HIV tests

OraSure reports earnings, third-quarter loss of $1.9 million

Editor's pick
The Morning Call
7 November 2013